Leading global health groups call on US to accelerate research

30 organizations issue recommendations for Congress, administration and FDA to find innovative ways to spur a new era of global health breakthroughs

2011-05-04

(Press-News.org) WASHINGTON, DC (May 3, 2011) – A coalition of 30 leading global health organizations that work on vaccines, drugs, and other tools and technologies that save lives today released a list of recommendations for US policymakers and regulators, calling for acceleration of scientific innovations and streamlining the approval of safe and affordable inventions in order to save more lives around the world.

The Global Health Technologies Coalition (GHTC), a group funded by the Bill & Melinda Gates Foundation and designed to give a greater voice for those advancing technologies for better health, recommended foremost in its annual report that in this difficult budget climate US policymakers should protect and sustain American investments in global health research and product development.

The report, which cited a long list of scientific achievements in the last year, said previous performance in global health has been remarkable and that more advances are now in the pipeline. Past funding has "yielded strong returns, resulting in new health tools with immense public health impact, in addition to fueling American job creation and domestic economic benefits," the report said.

"This past year we have seen breakthrough after breakthrough in global health—including vaccines, drugs, and tools that detect diseases," said Kaitlin Christenson, GHTC's director. "The impact of the investments in global health technologies is immense. These discoveries literally save thousands and thousands of lives every day in the developing world."

Christenson said US investment has been a principal factor in a host of critical advances in the last year, including: for the first time, a proof-of-concept showed that a gel called a microbicide can protect women against HIV and herpes; a new meningitis vaccine, costing less than 50 cents a dose, was launched in Africa and is expected to protect millions of people from death and disability; and the world's leading malaria vaccine candidate, RTS,S, is now in its last phase of clinical research in several countries in Africa.

"US support has been instrumental for all of these innovations," Christenson said. "What is encouraging is that US support has also helped accelerate other global health advances to come, in areas such as tuberculosis drugs, which would significantly shorten the amount of time a person would need to be on the medication. The advances are going to continue."

Dr. Alex Dehgan, science and technology advisor to the administrator of the US Agency for International Development, said that global health issues affected US citizens as well, and that technological innovation would help protect everyone.

"We are dealing with a set of interconnected problems around the world," he said. "What happens in Rwanda affects us in Topeka, and we need to pay attention to these things. That's why global health research and development is so important to us and is so connected to our own well-being. This report reminds us once again how US-funded global health research and development has made a critical and often life-saving difference in the lives of people around the world, and how it also offers multiple benefits to those of us in the United States."

Those benefits from global health research and development include major boosts to local and state economies throughout the country. One study in the state of California, for instance, found that global health supports about 350,000 jobs that generate $19.7 billion in annual salaries, wages, and benefits. In Washington state, global health supports 13,700 jobs that generate $1.7 billion in economic impact.

GHTC's report issues three sets of recommendations on funding policy, strengthening the Food and Drug Administration's role in global health, and innovative financing.

The 30 global health organizations' funding policy recommendations are: Sustaining and protecting US investments in global health research and product development. Developing concrete plans to incorporate research and development as a key priority within US global health and development programs. Ensuring that US investments in global health research are coordinated, efficient, and streamlined.

Its recommendations for FDA's increased role are: Releasing recommendations recently developed by its neglected diseases review group, and allow for public comment. Establishing stronger partnerships with other regulatory stakeholders, including the World Health Organization. Bolstering its internal expertise in neglected diseases, which could include inviting experts from developing countries to serve on its advisory boards. Increasing its engagement with groups developing global health tools. And Congress should include appropriations language to support the FDA's role in global health and fund the agency accordingly in next year's budget legislation.

Its recommendations for incentives and innovative financing for global health are: Establishing a cross-agency working group to explore US investment in incentives and innovative financing mechanisms for global health. Engaging with civil society, nongovernmental organizations, and private industry on this issue. Engaging with other governments and donors to explore and support incentives and innovative financing. Supporting a portfolio of incentives and financing mechanisms to stimulate needed research and development at all stages of the product development process. And conducting continuous rigorous assessments of each incentive and financing mechanism that the United States supports.

The 30 global health organizations that support the recommendations are:

Aeras Global TB Vaccine Foundation
AIDS Vaccine Advocacy Coalition
American Society of Tropical Medicine and Hygiene
BIO Ventures for Global Health
CD4 Initiative
CONRAD
Drugs for Neglected Diseases initiative
Elizabeth Glaser Pediatric AIDS Foundation
Family Health International
Foundation for Innovative New Diagnostics
GAVI Alliance
Global Alliance for TB Drug Development
Global Campaign for Microbicides
Global Health Council
Infectious Disease Research Institute
Innovative Vector Control Consortium
Institute for OneWorld Health
International AIDS Vaccine Initiative
International Partnership for Microbicides
International Vaccine Access Center
International Vaccine Institute
Medicines for Malaria Venture
PATH
PATH Malaria Vaccine Initiative
Population Council
Public Health Institute
Research!America
Sabin Vaccine Institute Global Network for Neglected Tropical Disease
Seattle BioMed
Treatment Action Group

###

About the Global Health Technologies Coalition:

The Global Health Technologies Coalition (GHTC) is a group of almost 40 nonprofit organizations working to increase awareness of the urgent need for tools that save lives in the developing world. These tools include new vaccines, drugs, microbicides, diagnostics, and other devices. The coalition advocates for increased and effective use of public resources, incentives to encourage private investment, and streamlined regulatory systems. For more information, visit www.ghtcoalition.org

END

ELSE PRESS RELEASES FROM THIS DATE:

Penn researchers develop technique for measuring stressed molecules in cells

2011-05-04

PHILADELPHIA — Biophysicists at the University of Pennsylvania have helped develop a new technique for studying how proteins respond to physical stress and have applied it to better understand the stability-granting structures in normal and mutated red blood cells. The research was conducted by Dennis Discher and Christine Krieger in the Molecular and Cell Biophysics Lab in Penn's School of Engineering and Applied Science, along with researchers from the New York Blood Center and the Wistar Institute. Discher's research was published online in the journal Proceedings ...

Study helps explain behavior of latest high-temp superconductors

2011-05-04

HOUSTON -- (May 3, 2011) -- A Rice University-led team of physicists this week offered up one of the first theoretical explanations of how two dissimilar types of high-temperature superconductors behave in similar ways. The research appears online this week in the journal Physical Review Letters. It describes how the magnetic properties of electrons in two dissimilar families of iron-based materials called "pnictides" (pronounced: NICK-tides) could give rise to superconductivity. One of the parent families of pnictides is a metal and was discovered in 2008; the other ...

MIT: Removable 'cloak' for nanoparticles helps them target tumors

2011-05-04

CAMBRIDGE, Mass. -- MIT chemical engineers have designed a new type of drug-delivery nanoparticle that exploits a trait shared by almost all tumors: They are more acidic than healthy tissues. Such particles could target nearly any type of tumor, and can be designed to carry virtually any type of drug, says Paula Hammond, a member of the David H. Koch Institute for Integrative Cancer Research at MIT and senior author of a paper describing the particles in the journal ACS Nano. Like most other drug-delivering nanoparticles, the new MIT particles are cloaked in a polymer ...

Ecstasy associated with chronic change in brain function

2011-05-04

Ecstasy – the illegal "rave" drug that produces feelings of euphoria and emotional warmth – has been in the news recently as a potential therapeutic. Clinical trials are testing Ecstasy in the treatment of post-traumatic stress disorder. But headlines like one in Time magazine's health section in February – "Ecstasy as therapy: have some of its negative effects been overblown?" – concern Ronald Cowan, M.D., Ph.D., associate professor of Psychiatry. His team reports in the May issue of Neuropsychopharmacology that recreational Ecstasy use is associated with a chronic ...

Webcam technology used to measure medications' effects on the heart

2011-05-04

Boston, MA – A common component in webcams may help drug makers and prescribers address a common side-effect of drugs called cardiotoxicity, an unhealthy change in the way the heart beats. Researchers at Brigham and Women's Hospital (BWH) have used the basic webcam technology to create a tool to look at the effects of medications in real time on heart cells, called cardiomyocytes. These findings were published in the journal, Lab on a Chip on April 11, 2011. Researchers developed a cost-effective, portable cell-based biosensor for real time cardiotoxicity detection using ...

'Nutcracker Man' had fundamentally different diet

2011-05-04

An ancient, bipedal hominid needs a new nickname. Paranthropus boisei, a 2.3 million to 1.2 million-year-old primate, whom researchers say is an early human cousin, probably didn't crack nuts at all as his common handle suggests. "Nutcracker Man" most likely ate grass and possibly sedges, said geochemist Thure Cerling, lead author of a study published in the May 2 online edition of the journal Proceedings of the National Academy of Sciences. Cerling and colleagues determined P. boisei's diet by analyzing carbon isotope ratios in the tooth enamel of 24 teeth from 22 ...

Formidable fungal force counters biofuel plant pathogens

2011-05-04

WALNUT CREEK, Calif.—Fungi play significant ecological and economic roles. They can break down organic matter, cause devastating agricultural blights, enter into symbiotic relationships to protect and nourish plants, or offer a tasty repast. For industrial applications, fungi provide a source of enzymes to catalyze such processes as generating biofuels from plant biomass. One large fungal group with such enzymes are the rust plant pathogens which cannot survive on their own so they use crops as hosts, leading to reduced yields and potentially hindering efforts to grow biomass ...

Marine snails get a metabolism boost

2011-05-04

Durham, NC – Most of us wouldn't consider slow-moving snails to be high-metabolism creatures. But at one point in the distant past, snail metabolism sped up, says a new study of marine snails in the journal Paleobiology. "Many of the marine snails we recognize today — such as abalone, conchs, periwinkles and whelks — require more than twice as much energy to survive as their ancestors did," said co-author Seth Finnegan of the California Institute of Technology. The findings come from a new analysis of snail fossils formed one to two hundred million years ago, during ...

Pistachios pummel pretzels as a weight-wise snack

2011-05-04

LOS ANGELES, May 3, 2011 – When it comes to healthy snacking and weight management, a new study bolsters the long-held view that not all calories are created equal. According to nutrition researchers at UCLA, choosing to snack on pistachios rather than pretzels as part of a healthy diet not only supports your body mass index (BMI) goals, but can support heart health too. The study, recently published in the Journal of the American College of Nutrition is especially significant in today's diet as snack foods account for more than a quarter of the total caloric intake ...

Rutgers offers hope in new treatment for spinal cord injuries

2011-05-04

Rutgers researchers have developed an innovative new treatment that could help minimize nerve damage in spinal cord injuries, promote tissue healing and minimize pain. After a spinal cord injury there is an increased production of a protein (RhoA) that blocks regeneration of nerve cells that carry signals along the spinal cord and prevents the injured tissue from healing. Scientists at the W.M. Keck Center for Collaborative Neuroscience and Quark Pharmaceuticals Inc. have developed a chemically synthesized siRNA molecule that decreases the production of the RhoA protein ...

Leading global health groups call on US to accelerate research

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: